Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy

Share |

What is patient-centricity... really?

Patient-centricity is a prominent buzzword but there is little consensus on the real meaning or the true purpose behind the engagement.

eyeforpharma has addressed, the WHAT, the WHY, and the HOW behind patient-centricity in their latest magazine:

  • WHAT: We speak AstraZeneca about how they have come to publish the first definition of patient-centricity, co-created with patients and carers
  • WHY: Pfizer, Merck and GSK give us their perspectives on how being patient-centric will deliver BOTH patient and shareholder value
  • HOW: We showcase some of the industry's most impactful patient initiatives - this year's eyeforpharma Award winners

With exclusive insights from the following industry leaders:

  • Guy Yeoman, Vice President, Patient Centricity at AstraZeneca
  • Andy Schmeltz, Senior Vice President, Patient & Health Impact at Pfizer
  • Julie Gerberding, Executive Vice President, Strategic Communications, Global Public Policy, and Population Health at Merck
  • Kate Knobil. Chief Medical Officer, Pharmaceuticals at GSK
  • Rob Gallo, Head of Corporate Communications - Europe and Canada at Takeda
  • Elizabeth Turcotte, Director, Patient Hub and UPL Lead at Bristol-Myers Squibb
  • Don Obazanek, Public Affairs Manager at AbbVie
Click here to download your copy of the magazine today..

sponsored by eyeforpharma
Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2017. Pharma Marketing Network. All rights reserved.